Teva Pharmaceutical Industries (TEVA) to Release Quarterly Earnings on Wednesday

Teva Pharmaceutical Industries (NYSE:TEVA) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 7th. Analysts expect Teva Pharmaceutical Industries to post earnings of $0.47 per share and revenue of $3.99 billion for the quarter.

Teva Pharmaceutical Industries Trading Up 1.3 %

Shares of TEVA opened at $16.40 on Tuesday. Teva Pharmaceutical Industries has a twelve month low of $12.47 and a twelve month high of $22.80. The stock has a market cap of $18.59 billion, a PE ratio of -11.31, a P/E/G ratio of 1.44 and a beta of 0.62. The company has a quick ratio of 0.75, a current ratio of 0.98 and a debt-to-equity ratio of 2.97. The business’s 50-day moving average price is $15.10 and its 200-day moving average price is $17.48.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on TEVA. StockNews.com upgraded shares of Teva Pharmaceutical Industries from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. Hsbc Global Res upgraded Teva Pharmaceutical Industries to a “strong-buy” rating in a research report on Monday, April 28th. Piper Sandler boosted their target price on Teva Pharmaceutical Industries from $23.00 to $30.00 and gave the stock an “overweight” rating in a research report on Friday, January 17th. Bank of America decreased their target price on Teva Pharmaceutical Industries from $23.00 to $20.00 and set a “buy” rating on the stock in a research note on Thursday, March 6th. Finally, Barclays dropped their price target on Teva Pharmaceutical Industries from $28.00 to $26.00 and set an “overweight” rating for the company in a research report on Thursday, January 30th. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $23.43.

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products.